BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7875767)

  • 41. L-NAME, nitric oxide and jejunal motility, blood flow and oxygen uptake in dogs.
    Alemayehu A; Lock KR; Coatney RW; Chou CC
    Br J Pharmacol; 1994 Jan; 111(1):205-12. PubMed ID: 8012697
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of effects of chronic and acute administration of NG-nitro-L-arginine methyl ester to the rat on inhibition of nitric oxide-mediated responses.
    Bryant CE; Allcock GH; Warner TD
    Br J Pharmacol; 1995 Apr; 114(8):1673-9. PubMed ID: 7541283
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exogenous cGMP prevents decrease in diuresis and natriuresis induced by inhibition of NO synthesis.
    Lahera V; Navarro J; Biondi ML; Ruilope LM; Romero JC
    Am J Physiol; 1993 Feb; 264(2 Pt 2):F344-7. PubMed ID: 8383451
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential effects of nitric oxide synthesis inhibition on basal blood flow and antidromic vasodilation in rat oral tissues.
    Kerezoudis NP; Olgart L; Edwall L
    Eur J Pharmacol; 1993 Sep; 241(2-3):209-19. PubMed ID: 7694863
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of prostaglandins on papillary blood flow and pressure-natriuretic response.
    Roman RJ; Lianos E
    Hypertension; 1990 Jan; 15(1):29-35. PubMed ID: 2295512
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nitric oxide, prostaglandins and angiotensin II in the regulation of renal medullary blood flow during volume expansion.
    Moreno C; Llinás MT; Rodriguez F; Moreno JM; Salazar FJ
    J Physiol Biochem; 2016 Mar; 72(1):1-8. PubMed ID: 26611113
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of neuronal nitric oxide synthase in response to hypertonic saline loading in rats.
    Wangensteen R; Rodríguez-Gomez I; Moreno JM; Chamorro V; Osuna A; Vargas F
    Acta Physiol Scand; 2004 Dec; 182(4):389-95. PubMed ID: 15569100
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interaction between nitric oxide and mineralocorticoids in the long-term control of blood pressure.
    Alvarez G; Osuna A; Wangensteen R; Vargas F
    Hypertension; 2000 Mar; 35(3):752-7. PubMed ID: 10720590
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Salt-induced increase in arterial pressure during nitric oxide synthesis inhibition.
    Salazar FJ; Alberola A; Pinilla JM; Romero JC; Quesada T
    Hypertension; 1993 Jul; 22(1):49-55. PubMed ID: 8319991
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Deficient production of nitric oxide induces volume-dependent hypertension.
    Lahera V; Salazar J; Salom MG; Romero JC
    J Hypertens Suppl; 1992 Dec; 10(7):S173-7. PubMed ID: 1291651
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nitric oxide of the supraoptic nucleus influences the salivary secretion, sodium renal excretion, urinary volume and arterial blood pressure induced by pilocarpine.
    Saad WA; Gutierrez LI; Guarda IF; Camargo LA; dos Santos TA; Saad WA; Simões S; Guarda RS
    Life Sci; 2004 Feb; 74(13):1593-603. PubMed ID: 14738904
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Renal intramedullary infusion of L-arginine prevents reduction of medullary blood flow and hypertension in Dahl salt-sensitive rats.
    Miyata N; Cowley AW
    Hypertension; 1999 Jan; 33(1 Pt 2):446-50. PubMed ID: 9931145
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Minimal effects of nitric oxide on spatial blood flow heterogeneity of the dog heart.
    Deussen A; Sonntag M; Flesche CW; Vogel RM
    Pflugers Arch; 1997 Apr; 433(6):727-34. PubMed ID: 9049163
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Responses to acute changes in arterial pressure on renal medullary nitric oxide activity in dogs.
    Majid DS; Said KE; Omoro SA
    Hypertension; 1999 Oct; 34(4 Pt 2):832-6. PubMed ID: 10523369
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detrimental hemodynamic effects of nitric oxide synthase inhibition in septic shock.
    Robertson FM; Offner PJ; Ciceri DP; Becker WK; Pruitt BA
    Arch Surg; 1994 Feb; 129(2):149-55; discussion 155-6. PubMed ID: 7508219
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of atrial natriuretic peptide in mediating the blood pressure-independent natriuresis elicited by systemic inhibition of nitric oxide.
    Dobrowolski L; Kuczeriszka M; Castillo A; Majid DS; Navar LG
    Pflugers Arch; 2015 Apr; 467(4):833-41. PubMed ID: 24953240
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessment of renal dopaminergic system activity in the nitric oxide-deprived hypertensive rat model.
    Soares-da-Silva P; Pestana M; Vieira-Coelho MA; Fernandes MH; Albino-Teixeira A
    Br J Pharmacol; 1995 Apr; 114(7):1403-13. PubMed ID: 7541690
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vascular responses to endothelin-1 following inhibition of nitric oxide synthesis in the conscious rat.
    Filep JG; Földes-Filep E; Rousseau A; Sirois P; Fournier A
    Br J Pharmacol; 1993 Nov; 110(3):1213-21. PubMed ID: 8298811
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nitric oxide and prostanoids protect the renal outer medulla from radiocontrast toxicity in the rat.
    Agmon Y; Peleg H; Greenfeld Z; Rosen S; Brezis M
    J Clin Invest; 1994 Sep; 94(3):1069-75. PubMed ID: 8083347
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Renal interstitial guanosine cyclic 3', 5'-monophosphate mediates pressure-natriuresis via protein kinase G.
    Jin XH; McGrath HE; Gildea JJ; Siragy HM; Felder RA; Carey RM
    Hypertension; 2004 May; 43(5):1133-9. PubMed ID: 15007031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.